Global Eisenmenger Syndrome Treatment Market Is Expanding Owing To Rising Prevalence Of Cardiovascular Diseases And Chronic Diseases

 

Overview:

A serious medical condition, Eisenmenger Syndrome occurs when the left side of the heart is deprived of oxygen. The heart's blood vessels abnormally get narrowed or are blocked, making it difficult for the blood to reach the lungs. The symptoms of this disorder include shortness of breath and blue or grayish skin. Treatment usually includes a variety of medications. Some of these medicines will help to control irregular heart rhythms and control high blood pressure. However, they might have some adverse effects, such as increased bleeding or kidney problems. In some cases, a heart and lung transplant is needed to treat the disorder. Although surgery is not always fatal, it is a very risky procedure. Surgery can also lead to emotional and physical complications. For children, the recovery time can be long. Similarly, parents who have a child with the syndrome may face complications such as developmental delays.


Eisenmenger Syndrome Treatment

Market Dynamics:  

Increasing research and developmental activities are estimated to augment growth of the global Eisenmenger Syndrome Treatment Market over the forecast period. For instance, Aerovate Therapeutics initiated their phase 2b/3 clinical trials for testing imatinib in December 2021. This trial will help in treating people suffering from rare cardiovascular disease. Moreover, low implementation of treatments is anticipated to restrain growth of the global Eisenmenger syndrome treatment market over the forecast period.

 Impact of COVID-19:

Several nations worldwide had to implement strict nationwide lockdown restrictions, owing to the rising number of COVID-19 cases. Many supply chains were disrupted and several industries were shut temporarily, due to government restrictions. The healthcare sector was also affected owing to the rising number of positive cases of COVID-19. Majority research activities were focusing on developing vaccines and drugs for COVID-19. Hospitals were prioritizing COVID-19 patients over other diseases. This hampered the growth of the Eisenmenger Syndrome Treatment Market during the pandemic. However, now that many regulations have been relaxed and CIVID- 19 cases have also decreased the market is estimated to witness growth.

Key Takeaways:

The global Eisenmenger Syndrome Treatment Market is expected to witness high growth, exhibiting CAGR of XX% over the forecast period, due to increasing product approvals. For instance, a multinational pharmaceutical company Alembic Pharmaceuticals gained approval from the US FDA for marketing Selexipag tablets in December 2021.

North America is anticipated to witness significant growth in the global Eisenmenger Syndrome Treatment Market over the forecast period, owing to growing technological advancements and increasing research and development.

Major players operating in the global Eisenmenger Syndrome Treatment Market are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Novartis AG, AstraZeneca plc., Merck & Co., Inc., Gilead Sciences, Inc., Mylan N.V., GlaxoSmithKline plc., Bayer AG, and Actelion Pharmaceuticals Ltd.

Comments

Post a Comment

Popular posts from this blog

Electric Wheelchair Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Image
  Electric Wheelchair A wheelchair is used to help those who are unable to walk due to disease, accident, or disability. Manual wheelchairs and power or electric wheelchairs are the two types of wheelchairs available. A wheelchair is used for mobility by a disabled person or someone who is unable to walk due to an injury or illness. They are suitable for both outdoor and indoor use. Electric Wheelchairs that are customised for everyday usage or specialised to a certain field activity are also available. Wheelchairs reduce the user's issues or suffering, such as back pain, sores, digestion, and breathing. Those with upper body strength often use manual wheelchairs, whereas patients who are fatigued typically utilise electric wheelchairs. According to Coherent Market Insights, The global Electric Wheelchair Market is estimated to be valued at US$ 6,387.3 Mn in 2021, and is expected to exhibit a CAGR of 10.7% over the forecast period (2021-2028). Automated movement systems have ...
Read more

The Global Benzocaine Market Size Is Expected To Exhibit A Cagr Of 2.70% Over The Forecast Period (2020-2027).

Image
  Benzocaine, also known as americaine or anaesthesin, is an organic compound that belongs to the benzoic acid esters class. Benzocaine is a pharmaceutical active ingredient with a variety of medicinal properties. It is used to treat sexual disorders like premature ejaculation, as a topical anaesthetic in diseases like mouth and esophageal ulcers, as a pain reliever in dental diseases like tooth decay and dental caries, and to treat skin irritation like vaginal irritation in females. Benzocaine API is a solid physical substance that is slightly soluble in water and has the chemical name Ethyl 4-aminobenzoate.   The global benzocaine market size is estimated to be valued at US$ 128.9 million in 2020 and is expected to exhibit a CAGR of 2.70% over the forecast period (2020-2027). Benzocaine is an effective numbing agent that is used prior to surgical procedures. It prevents nerve signals from reaching the brain from a specific part of the body. It is classified as a local anaest...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more